Ph Struct
Prohance Injection, Solution
Product Images NDC 0270-1111
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prohance (NDC 0270-1111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 mL Syringe (Prohance 10 mL Syringe)
This is a description for Gadoteridol Injection, a prescription medication for intravenous use. Each milliliter of the sterile aqueous solution contains 279.3 mg of gadoteridol, along with calteridol calcium and tromethamine. The pH is adjusted to 6.5-8.0 using hydrochloric acid and/or sodium hydroxide. It is supplied in single-dose syringes, and any unused portion should be discarded. The syringe should also be discarded if the seal is broken or if leaking is observed. The product should be stored at 25°C and protected from light. The medication is manufactured for Bracco Diagnostics Inc., with the manufacturing site located in Germany.*
5 mL Vial (Prohance 5 mL Vial)
This is a description of a medication called ProHance. Each milliliter of the sterile aqueous solution contains 279.3 mg of gadoteridol along with 0.23 mg of calcium and 1.21 mg of tromethamines. The pH of the solution is adjusted to 6.5-8.0 with hydrochloric acid and/or sodium hydroxide. This medication is intended for intravenous use and should be used as directed. It is manufactured for Bracco Diagnostics Inc. by BIPSO GmbH in Singen, Germany. Please refer to the insert for detailed indications and dosage information.*
Syringe (Prohance Syringe)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
